PTC Therapeutics, Inc. PTCT 深 滬
等待開盤 03-26 09:30:00 美东时间
66.75
+2.210
+3.42%
華盛通- 最 高67.45
- 今 開65.24
- 成交量 68.48万股
- 最 低 64.88
- 昨 收 64.54
- 總市值 55.25亿
- 52周最高 87.50
- 市盈率 靜 8.58
- 換手率 0.83%
- 52周最低 35.95
- 委 比 -87.26%
- 總股本 8277.47万
- 歷史最高 87.50
- 量 比 0.50
- 振 幅 3.98%
- 歷史最低 4.03
- 每 手 1
- 風險率 12.11%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多PTC Therapeutics Appoints Biotech Banking Pioneer Jessica Chutter to Board of Directors
WARREN, N.J., March 25, 2026 /PRNewswire/ -- PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced the appointment of Jessica Chutter to its Board of Directors. Ms. Chutter is a highly acco...
03-25 20:30
新浪财经ESG：PTC Therapeutics Inc. MSCI（明晟）ESG评级调降至B
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
03-24 10:28
Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Pyxis Oncology, Inc. reported updates on its lead candidate MICVO, including completion of target enrollment in a Phase 1 monotherapy study for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) in the first quarter of 2026. The company also announced updated data expected in mid-2026, which will include patients treated with modified weight-based dosing. Additionally, Pyxis Oncology shared financial results for 2025, includin...
03-23 11:00
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WARREN, N.J., March 13, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on March 10, 2026, the company approved non-statutory stock options to purchase an agg...
03-14 04:30
美股大行评级 | 大摩将康宁目标价从103美元升至127美元；潜在涨幅1779.7%！IGC Pharma获Ascendiant Capital升目标价至5美元
今日重点评级关注：Ascendiant Capital：维持IGC Pharma"买入"评级，目标价从4.75美元升至5美元；Brookline Capital：维持C4 Therapeutics"买入"评级，目标价从20美元升至30美元
02-24 10:27
美股大行评级 | 潜在涨幅214.14%！HC Wainwright & Co.：Ardelyx获机构升目标价至18美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Ardelyx"买入"评级，目标价从10美元升至18美元；Truist Securities：维持Praxis Precision Medicine"买入"评级，目标价从500美元升至700美元
02-23 08:56
B of A Securities Maintains Buy on PTC Therapeutics, Lowers Price Target to $93
B of A Securities analyst Tazeen Ahmad maintains PTC Therapeutics (NASDAQ:PTCT) with a Buy and lowers the price target from $97 to $93.
02-20 20:40
U.S. RESEARCH ROUNDUP-Dropbox, Etsy, Zscaler
U.S. RESEARCH ROUNDUP-Dropbox, Etsy, Zscaler Feb 20 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Dropbox, Etsy and Zscaler , on Friday. HIGHLIGHTS * Akamai Technologies Inc AKAM.O : Scotiabank raises target price to $
02-20 15:08
财报速睇 | PTC Therapeutics, Inc. 2025财年Q4营收1.65亿美元，同比下降22.5%；归母净利润亏损1.35亿美元，同比亏损扩大104.5%
华盛资讯2月20日讯，PTC Therapeutics, Inc.公布2025财年Q4业绩，公司Q4营收1.65亿美元，同比下降22.5%，归母净利润亏损1.35亿美元，同比亏损扩大104.5%。
02-20 06:37
PTC Therapeutics Tops 2025 Revenue Guidance, Boosts Cash
PTC Therapeutics ( ($PTCT) ) just unveiled an announcement. On Feb. 19, 2026, P...
02-20 05:30
